135 related articles for article (PubMed ID: 30993482)
21. Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience.
Markman M; Lewis JL; Saigo P; Hakes T; Jones W; Rubin S; Reichman B; Barakat R; Curtin J; Almadrones L
Cancer; 1993 Jan; 71(2 Suppl):634-7. PubMed ID: 8420687
[TBL] [Abstract][Full Text] [Related]
22. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
23. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer.
Rauh-Hain JA; Rodriguez N; Growdon WB; Goodman AK; Boruta DM; Horowitz NS; del Carmen MG; Schorge JO
Ann Surg Oncol; 2012 Mar; 19(3):959-65. PubMed ID: 21994038
[TBL] [Abstract][Full Text] [Related]
24. Drug therapy for gynaecological cancer in older women.
van Rijswijk RE; Vermorken JB
Drugs Aging; 2000 Jul; 17(1):13-32. PubMed ID: 10933513
[TBL] [Abstract][Full Text] [Related]
25. Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer.
Xu X; Deng F; Lv M; Ren B; Guo W; Chen X
J Ovarian Res; 2016 Dec; 9(1):85. PubMed ID: 27912779
[TBL] [Abstract][Full Text] [Related]
26. Patterns of chemotherapy use for women with ovarian cancer: a population-based study.
Cress RD; O'Malley CD; Leiserowitz GS; Campleman SL
J Clin Oncol; 2003 Apr; 21(8):1530-5. PubMed ID: 12697877
[TBL] [Abstract][Full Text] [Related]
27. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
[TBL] [Abstract][Full Text] [Related]
28. Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer.
Uyar D; Frasure HE; Markman M; von Gruenigen VE
Gynecol Oncol; 2005 Sep; 98(3):403-8. PubMed ID: 16000216
[TBL] [Abstract][Full Text] [Related]
29. Systemic Treatment Patterns With Advanced or Recurrent Non-small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database Study.
Wang F; Mishina S; Takai S; Le TK; Ochi K; Funato K; Matsuoka S; Ohe Y
Clin Ther; 2017 Jun; 39(6):1146-1160. PubMed ID: 28527959
[TBL] [Abstract][Full Text] [Related]
30. Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.
Onda T; Kamura T; Ishizuka N; Katsumata N; Fukuda H; Yoshikawa H;
Jpn J Clin Oncol; 2004 Jan; 34(1):43-5. PubMed ID: 15020662
[TBL] [Abstract][Full Text] [Related]
31. Whole abdominopelvic radiotherapy using intensity-modulated arc therapy in the palliative treatment of chemotherapy-resistant ovarian cancer with bulky peritoneal disease: a single-institution experience.
De Meerleer G; Vandecasteele K; Ost P; Delrue L; Denys H; Makar A; Speleers B; Van Belle S; Van den Broecke R; Fonteyne V; De Neve W
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):775-81. PubMed ID: 20421155
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma.
Kuhn W; Rutke S; Späthe K; Schmalfeldt B; Florack G; von Hundelshausen B; Pachyn D; Ulm K; Graeff H
Cancer; 2001 Nov; 92(10):2585-91. PubMed ID: 11745193
[TBL] [Abstract][Full Text] [Related]
33. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
du Bois A; Kristensen G; Ray-Coquard I; Reuss A; Pignata S; Colombo N; Denison U; Vergote I; Del Campo JM; Ottevanger P; Heubner M; Minarik T; Sevin E; de Gregorio N; Bidziński M; Pfisterer J; Malander S; Hilpert F; Mirza MR; Scambia G; Meier W; Nicoletto MO; Bjørge L; Lortholary A; Sailer MO; Merger M; Harter P;
Lancet Oncol; 2016 Jan; 17(1):78-89. PubMed ID: 26590673
[TBL] [Abstract][Full Text] [Related]
34. Under-treatment of elderly patients with ovarian cancer: a population based study.
Fourcadier E; Trétarre B; Gras-Aygon C; Ecarnot F; Daurès JP; Bessaoud F
BMC Cancer; 2015 Nov; 15():937. PubMed ID: 26610814
[TBL] [Abstract][Full Text] [Related]
35. Ovarian cancer in elderly women.
Lambrou NC; Bristow RE
Oncology (Williston Park); 2003 Aug; 17(8):1075-81; discussion 1081, 1085-6, 1091. PubMed ID: 12966676
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV).
Glasgow MA; Yu H; Rutherford TJ; Azodi M; Silasi DA; Santin AD; Schwartz PE
J Surg Oncol; 2013 Feb; 107(2):195-200. PubMed ID: 22648987
[TBL] [Abstract][Full Text] [Related]
37. Serum CA 125 Level after Neoadjuvant Chemotherapy is Predictive of Prognosis and Debulking Surgery Outcomes in Advanced Epithelial Ovarian Cancer.
Matsuhashi T; Takeshita T; Yamamoto A; Kawase R; Yamada T; Kurose K; Doi D; Konnai K; Onose R; Kato H
J Nippon Med Sch; 2017; 84(4):170-176. PubMed ID: 28978897
[TBL] [Abstract][Full Text] [Related]
38. [Trend in proportion and clinicopathological characteristics of young women with stage Ⅰa2 to Ⅱa2 cervical cancer].
Wang W; Hao M; Chen CL; Liu P; Ling B; Kang S; Lu AW; Wang WL; Zhao WD; Zhu QY; Zhao YY; Zhao HW; Jin SL; Ni Y; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):666-672. PubMed ID: 31648442
[No Abstract] [Full Text] [Related]
39. Age-related differences in breast cancer treatment.
August DA; Rea T; Sondak VK
Ann Surg Oncol; 1994 Jan; 1(1):45-52. PubMed ID: 7834427
[TBL] [Abstract][Full Text] [Related]
40. Potential risk factors associated with prognosis of neoadjuvant chemotherapy followed by interval debulking surgery in stage IIIc-IV high-grade serous ovarian carcinoma patients.
Zhang J; Liu N; Zhang A; Bao X
J Obstet Gynaecol Res; 2018 Sep; 44(9):1808-1816. PubMed ID: 30019801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
